Clinical trial
Scoliosis Treatment: Evaluating Patient Suitability (STEPS)-A Multicenter Prospective Observational Cohort Study Comparing Short-Segment and Long-Segment Fusion in Degenerative Scoliosis
NCT07891676 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Scoliosis Treatment: Evaluating Patient Suitability (STEPS)-A Multicenter Prospective Observational Cohort Study Comparing Short-Segment and Long-Segment Fusion in Degenerative Scoliosis
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- January 31, 2029
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative scoliosis
Arms
As registered; 2 arms.
-
Short-Segment Fusion
Participants undergoing instrumented spinal fusion involving fewer than four fused motion segments, selected through routine clinical decision-making.
-
Long-Segment Fusion
Participants undergoing instrumented spinal fusion involving four or more fused motion segments, selected through routine clinical decision-making.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Achievement of the Minimum Clinically Important Difference in the Scoliosis Research Society-22r Subtotal Score
Proportion of participants achieving an increase of more than 0.98 points from baseline in the Scoliosis Research Society-22r (SRS-22r) subtotal score. The subtotal score includes the function/activity, pain, self-image, and mental health domains and excludes the satisfaction domain. Scores range from 1 to 5, with higher scores indicating better health-related quality of life.
Lead sponsor's other trials
Xuanwu Hospital, Beijing, most recent start first.
+358 more trials See the organization page